UPDATE 2-Roche faces further delay in $4.3 bln Spark deal amid FTC review

Roche on Friday announced another extension of its $4.3 billion offer for gene therapy specialist Spark Therapeutics, this time until June 3, saying a review by U.S. authorities is taking longer than originally expected.

from Reuters: Company News https://reut.rs/2WdMESV
via IFTTT